- 5 - 5 Parks et al. 2014 P=NS P=NS P=NS P=NS P<0,001 P=0,57 - 8±7 - 7±6 Well-matched 400 800 325 280 (215, 17 1(5,9%) 4(10,5%) (188, (500, 5,9% 10,5% (214, 12 ± 5 22 ± 8 - / - / 318) Included in 1050) 1125) 430) Shimada(32) Xiong et al. 2001 7LLS 38 HCC 0 0 0 0 0 - 41,2% - 50% 2012, Yin et al Fukuoka-Japan 2013 and 10subS P=0,65 Parks et al. P=0,99 P=0,08 P=0,99 P=0,18 P<0,001 2014 P=0,54 Long(33) 100 2014 173 - HCC 0 0 4(2,3%) 4(2,4%) - - - 112 ± 56 . 6.5 ± 2.0 - 2(1,2%) - Ho Chi Vietnam Hwang(34) Malign 410.0 ± 214.9 ± 2013 744 - + 2(0,27%) - 34(4,6%) 52(7%) - - 67(9%) - - 8.6 ± 5.0 - - - 451.4 114.1 Benign Multic-Korea 29 Zhen(35) 3S 2010 - HCC 0 - 3(10,3%) 9(31,03%) - 164 - 0 - 120 - 7,08 - 0 - Guang 17BiS China 9LLS SERIES Lai(36) 19 2010 - CLINICAL Hong Kong-China 19LLS 2010 9 - Malign Hand-assisted 22 Santambrogio(38) 5BiS 2009 - HCC 0 - 13,6% 2(9%) - 18372 - 1(4,5%) - - 5,41 - 0 - Milan-Italy 9S
- 5 - 5 Parks et al. 2014 P=NS P=NS P=NS P=NS P<0,001 P=0,57 Shimada(32) Fukuoka-Japan 2001 17 7LLS 10subS 38 HCC 0 0 0 1(5,9%) 4(10,5%) 400 (188, 1050) 800 (500, 1125) 5,9% 10,5% 325 (214, 430) 280 (215, 318) 12 ± 5 22 ± 8 0 0 - 8±7 - / - 41,2% - 7±6 - / - 50% Well-matched Included in Xiong et al. 2012, Yin et al 2013 and Parks et al. 2014 P=0,99 P=0,08 P=0,99 P=0,18 P<0,001 P=0,65 P=0,54 CLINICAL SERIES Long(33) Ho Chi 2014 173 - HCC 0 0 4(2,3%) 4(2,4%) - 100 - - 112 ± 56 . 6.5 ± 2.0 - 2(1,2%) - Hwang(34) Multic-Korea 2013 744 - Malign + Benign 2(0,27%) - 34(4,6%) 52(7%) - 410.0 ± 451.4 - 67(9%) - 214.9 ± 114.1 - 8.6 ± 5.0 - - - Zhen(35) Guang 2010 29 3S 17BiS 9LLS - HCC 0 - 3(10,3%) 9(31,03%) - 164 - 0 - 120 - 7,08 - 0 - Lai(36) Hong Kong-China 2010 19 19LLS - 2010 9 - Malign Hand-assisted Santambrogio(38) Milan-Italy 2009 22 5BiS 9S - HCC 0 - 13,6% 2(9%) - 18372 - 1(4,5%) - - 5,41 - 0 - Vietnam China
SLA_2015_03_13_WAKABAYASHI_1402188_SDC2.docx